Literature DB >> 9592138

RNA heptamers that direct RNA cleavage by mammalian tRNA 3' processing endoribonuclease.

M Nashimoto1, S Geary, M Tamura, R Kaspar.   

Abstract

Mammalian tRNA 3' processing endoribonuclease (3' tRNase) can recognize and cleave any target RNA that forms a precursor tRNA-like complex with another RNA. Various sets of RNA molecules were tested to identify the smallest RNA that can direct target RNA cleavage by 3' tRNase. A 3' half tRNAArgwas cleaved efficiently by 3' tRNase in the presence of small 5' half tRNAArgvariants, the D stem-loop region of which was partially deleted. Remarkably, 3' tRNase also cleaved the 3' half tRNAArgin the presence of a 7 nt 5' tRNAArg composed only of the acceptor stem region with a catalytic efficiency comparable with that of cleavage directed by an intact 5' half tRNAArg. The catalytic efficiency of cleavage directed by the heptamer decreased as the stability of the T stem-loop structures of 3' half tRNAArg variants decreased. No heptamer-directed cleavage of a 3' half tRNAArg without T stem base pairs was detected. A heptamer also directed cleavage of an HIV-1 RNA containing a stable hairpin structure. These findings suggest that in the presence of an RNA heptamer, 3' tRNase can discriminate and eliminate target RNAs that possess a stable hairpin adjacent to the heptamer binding sequence from a large complex RNA pool.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9592138      PMCID: PMC147582          DOI: 10.1093/nar/26.11.2565

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

1.  RNA editing--a novel genetic phenomenon?

Authors:  L Simpson
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

Review 2.  Small nucleolar RNAs guide ribosomal RNA methylation.

Authors:  D Tollervey
Journal:  Science       Date:  1996-08-23       Impact factor: 47.728

3.  Antisense aims for a renaissance.

Authors:  W Roush
Journal:  Science       Date:  1997-05-23       Impact factor: 47.728

Review 4.  Anti-gene therapy: the use of ribozymes to inhibit gene function.

Authors:  L A Couture; D T Stinchcomb
Journal:  Trends Genet       Date:  1996-12       Impact factor: 11.639

5.  Improved parameters for prediction of RNA structure.

Authors:  D H Turner; N Sugimoto; J A Jaeger; C E Longfellow; S M Freier; R Kierzek
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1987

6.  Specific cleavage of target RNAs from HIV-1 with 5' half tRNA by mammalian tRNA 3' processing endoribonuclease.

Authors:  M Nashimoto
Journal:  RNA       Date:  1996-06       Impact factor: 4.942

7.  Distribution of both lengths and 5' terminal nucleotides of mammalian pre-tRNA 3' trailers reflects properties of 3' processing endoribonuclease.

Authors:  M Nashimoto
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

8.  Characterization of oligonucleotide transport into living cells.

Authors:  S L Loke; C A Stein; X H Zhang; K Mori; M Nakanishi; C Subasinghe; J S Cohen; L M Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

9.  Potent and selective inhibition of gene expression by an antisense heptanucleotide.

Authors:  R W Wagner; M D Matteucci; D Grant; T Huang; B C Froehler
Journal:  Nat Biotechnol       Date:  1996-07       Impact factor: 54.908

10.  Enzymatic approaches to probing of RNA secondary and tertiary structure.

Authors:  G Knapp
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

View more
  15 in total

1.  Intracellular mRNA cleavage by 3' tRNase under the direction of 2'-O-methyl RNA heptamers.

Authors:  Masato Tamura; Chikako Nashimoto; Noriko Miyake; Yasushi Daikuhara; Kozo Ochi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

2.  A novel 4-base-recognizing RNA cutter that can remove the single 3' terminal nucleotides from RNA molecules.

Authors:  Hiroaki Takaku; Asako Minagawa; Masamichi Takagi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2004-06-28       Impact factor: 16.971

3.  The N-terminal half-domain of the long form of tRNase Z is required for the RNase 65 activity.

Authors:  Hiroaki Takaku; Asako Minagawa; Masamichi Takagi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2004-08-18       Impact factor: 16.971

4.  A candidate prostate cancer susceptibility gene encodes tRNA 3' processing endoribonuclease.

Authors:  Hiroaki Takaku; Asako Minagawa; Masamichi Takagi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

Review 5.  TRUE Gene Silencing.

Authors:  Masayuki Nashimoto
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

6.  Endonucleolytic processing of CCA-less tRNA precursors by RNase Z in Bacillus subtilis.

Authors:  Olivier Pellegrini; Jamel Nezzar; Anita Marchfelder; Harald Putzer; Ciarán Condon
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

7.  TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents.

Authors:  Arisa Haino; Tatsuya Ishikawa; Mineaki Seki; Masayuki Nashimoto
Journal:  J Vis Exp       Date:  2016-06-02       Impact factor: 1.355

8.  Elimination of specific miRNAs by naked 14-nt sgRNAs.

Authors:  Masayuki Takahashi; Reyad A Elbarbary; Mayumi Abe; Mari Sato; Tetsuo Yoshida; Yoji Yamada; Masato Tamura; Masayuki Nashimoto
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

9.  Modulation of gene expression by human cytosolic tRNase Z(L) through 5'-half-tRNA.

Authors:  Reyad A Elbarbary; Hiroaki Takaku; Naoto Uchiumi; Hiroko Tamiya; Mayumi Abe; Masayuki Takahashi; Hiroshi Nishida; Masayuki Nashimoto
Journal:  PLoS One       Date:  2009-06-15       Impact factor: 3.240

10.  Optimization and characterization of tRNA-shRNA expression constructs.

Authors:  Lisa J Scherer; Richard Frank; John J Rossi
Journal:  Nucleic Acids Res       Date:  2007-04-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.